Tue, Jul 22, 2014, 6:46 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

CBRE Clarion Global Real Estate Message Board

philpt 6 posts  |  Last Activity: Jul 16, 2014 7:53 PM Member since: Jun 3, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Which one to own the share?

  • Reply to

    Read it

    by philpt Jun 13, 2014 2:17 PM
    philpt philpt Jun 20, 2014 5:33 AM Flag

    You were completely wrong. If you listen to what I said you already made money now. GTIV is now trading at $15.24 per share, 1.34 point higher than its original price ($13.90) at the time I posted my message here.

  • philpt by philpt Jun 13, 2014 2:17 PM Flag

    Kindred Healthcare (KND) Considering Raised Bid for Gentiva Health (GTIV); Activists Circle
    1:17 PM ET, 06/04/2014 - Street Insider

    In the healthcare sector, there is speculation that Kindred Healthcare (NYSE: KND) is prepared to raise its bid for Gentiva Health Services (NASDAQ: GTIV) to $15-$16 per share in what might be its 'best and final offer' to acquire the nation's largest providers of home health, hospice and community care services.
    In mid-May, Kindred announced a proposal to acquire all of the outstanding shares of common stock of Gentiva for a combination of $7.00 per share in cash and $7.00 of Kindred common stock. Kindred also offered to increase its offer to 100% cash if the Gentiva Board so elects. The offer came at a significant 64% premium over the closing price of Gentiva common stock on May 14, 2014, and a 59% premium over Gentiva s 60-day volume-weighted average closing price.
    So far, Gentiva Health has been unwilling to enter talks with Kindred and has adopted a poison pill. The Board concluded that the Kindred proposal "significantly undervalues Gentiva and its attractive prospects for growth and value creation."
    In addition to market talk of a raised and 'final offer', there is chatter activist investors could push the company to enter substantive talks with Kindred. In fact, there is already an activist investor in Gentiva stock. North Tide Capital held a 1.4% stake in Gentiva at the end of the latest quarter. Recently the activist firm made headway at Healthways (NASDAQ: HWAY) which nominated three directors selected by North Tide for election to its Board of Directors. White it is unclear if North Tide Capital will step up with an activist effort on Gentiva, it is clear that many investors would like to see the two sides come to an agreement. When announcing the deal, Kindred said 20% of Gentiva s shareholders, who are also shareholders of Kindred, would support the transaction and favor the stock of the combined company if given the op

  • Reasons:
    1) Possible another bid pending
    2) The bid is low
    3) The deal is still on going to resolve the pending issues (e.g. debt, lay off, management change etc..)
    I would say just be patient if you already have the shares.
    Sell your holding in half if you already make money but hold on if you want to get back to at least your initial entry point or possibly higher.

  • philpt philpt Jun 10, 2014 3:36 PM Flag

    I agree. I did the same thing at 7,14

  • I am watching closely the share price as the government investigation is going on. There is no smoke if there was no fire.
    I like the company investment strategies but today's news was bother me so I am stay in the sideline.

IGR
9.09+0.06(+0.61%)Jul 22 4:02 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.